FundCena Ventures Fund I
Venture capital opportunity within Cena Ventures. Explore the secure opportunity page for the full company overview.
Brand visibility in AI-powered search.




AI-native / A category-defining private-capital operating system
Capital. Expertise. Relationships.
Connected by intelligence.
Put to work by you.
Discover where you can contribute. Explore investments, advisory, board and operating opportunities.
One profile. More possibilities →Agora™ Intelligence
FundVenture capital opportunity within Cena Ventures. Explore the secure opportunity page for the full company overview.
FundGraphora’s dedicated fund strategy for selected Y Combinator S26 companies.
AI-native platform companies led by CEOs selected by Trevor Silver. Easy Apply to the fund as a limited partner or explore separate company SPVs.
A Graphora fund connecting healthcare innovation, AI and strategic capital across 14 selected companies.
A Graphora fund connecting consumer products, creator businesses, hospitality and media.
CompanyExpress non-binding interest in Graphora’s planned January 2027 seed round. Final terms, investment documents and allocations remain subject to confirmation.
CompanyW is a personal-care brand co-founded by Jake Paul, focused on everyday body care and fragrance for men.
CompanyOpenEvidence is a medical knowledge platform using AI to help healthcare professionals work with clinical information.
CompanyNovaro Capital is a New York-based investment manager working across real estate and infrastructure.
CompanyRed Sky Health develops Daniel, an AI platform focused on insurance-claim denial remediation for healthcare providers.
CompanyBelay’s MedLocker combines secure storage with access to emergency medicines in shared environments.
CompanySensars develops peripheral-nerve stimulation technology with a focus on restoring sensory information.
Protelicious creates whey-protein products that combine a nutrition focus with a gourmet food experience.
CompanyWardly AI develops tools to prepare healthcare teams for patient visits using information from records, referrals and patient conversations.
CompanyThe TeleDentists provides access to licensed dentists through virtual consultations.
CompanyCounterX Therapeutics is developing antibody and vaccine approaches related to opioid overdose and addiction.
CompanyOlivo Sciences applies AI and multimodal data to precision drug development for brain disorders.
CompanyDigostics develops at-home oral glucose tolerance testing and related diagnostic services.
CompanyEvren Technologies is developing non-invasive vagus nerve stimulation devices for research into post-traumatic stress disorder.
CompanyAlzheimer’s Treatment Centers of America, or ATCA, brings physicians, diagnostics and technology together around cognitive-health care.
CompanyXenter develops wireless technology and medical intelligence for medical devices and healthcare data.
CompanyTsenta develops an AI agent to help people discover relevant jobs and manage the application process.
CompanyErinys builds technology and operating infrastructure for AI-native law firms.
CompanyCosmic Robotics builds autonomous equipment for construction, beginning with large-scale infrastructure.
CompanyGutGutGoose develops personalized probiotics using microbiome sequencing and modeling.
CompanyAgnost AI analyzes production conversations and traces to identify where AI agents fail.
CompanyPluto is an AI career agent designed to understand a professional’s experience, goals and preferences.
CompanyPeer is an AI-native freight brokerage that supports shipments from quoting through delivery.
CompanyPalette develops AI tools for generating and editing media using natural-language direction and brand context.
CompanyEgoist Machines is building AI Passport, a user-owned context layer for AI applications.
CompanyDenta is building a dental insurance business with technology-centered administration.
CompanyInsurf develops data and decision tools for health coverage and provider administration.
CompanyKara develops high-purity diamond wafers and components for advanced hardware.
CompanyLamb Labs develops Model Processing Units, a hardware approach to AI inference.
CompanyDecawork develops company-specific models that evaluate actions taken by AI agents.
CompanyTareBio is developing a vaccine platform that starts from the body’s existing immune response.
Lumeria develops the Lumoscope, an at-home skin-imaging approach paired with longitudinal monitoring.
Edgerun builds powered exoskeletons for military mobility and endurance.
Boon helps businesses understand how AI assistants describe their brands and how buyers discover vendors through AI.
CompanyMolli focuses on health-plan access for self-employed professionals, contractors and other independent workers.
Graphora presents Forty Love as a tennis-hospitality opportunity within its Creator Capital & CPG strategy.
CompanyLongevity Revolution is a documentary project exploring developments in longevity science and technology.
CompanyMy Maya is developing an AI companion designed to preserve personal context across healthcare conversations and everyday life.
CompanySolus is a healthcare data platform developed by Seamless Integration Group, Inc.
CompanyAvoca Systems develops AI-powered operations software for radiology providers.
No investments match this search. Try a different name or strategy.
Help companies navigate industry decisions, partnerships and growth.
Explore available roles ↗Contribute governance experience, considered judgment and leadership.
Explore available roles ↗Bring hands-on experience to products, teams and companies.
Explore available roles ↗These are participation pathways, not specific vacancies. Graphora Ascent™ shows available roles and their individual requirements. Professional participation does not necessarily require an investment.
Want to build Graphora itself? Explore Careers →From possibility to participation
A connection between what a company needs
and what you can bring.
A company, investment or professional role enters the picture.
Graphora relates professional experience and interests to relevant opportunities.
You explore, apply and engage, with clear requirements and next steps.
Confirmed investments, appointments and partnerships can become milestones.
A match is a potential connection—not approval, an allocation, or a promised outcome.
My Graphora
Your profile, personalized opportunities, badges and applications. Know where you stand and what to do next.
Open My Graphora ↗Take the ANDE™ guided tour →Sign in to see your own opportunities, readiness and next steps.
A simpler way in
Connect LinkedIn for membership, then add professional details your way: authorize a profile import, upload a LinkedIn PDF or résumé, or enter details manually. These details are optional—you can explore first and add them later.
Connecting LinkedIn alone does not import your full career history. A photo and document upload are optional. You can review and edit professional details before or after saving.
Your professional story
✓ Experience and expertise
✓ Professional background
✓ Your review and confirmation
You stay in control of what you confirm.A more connected future
Meaningful relationships and introductions to CEOs, investors, customers and advisors.
Express interest & share feedback ↗A connected view of your private investments, built around your portfolio.
Express interest & share feedback ↗A place for perspectives, conversations and relationships across the Graphora network.
Express interest & share feedback ↗Roadmap features are not currently available. Timing and final plan availability may change. No trading or liquidity is implied.
Opportunity pipeline
Investments and the pipeline ahead
| Investments | Count | Fundraising target |
|---|---|---|
| Funds | 5 | $60M |
| Companies | 40 | $84.225M |
| Total | 45 | $144.225M |
Available to explore on Graphora.
Explore these opportunities on Graphora now. Some are information-only or marked coming soon; each opportunity page shows whether applications are open.
What happens next: Explore the page, check its status, then apply if eligible.
Pending release—not yet live.
Opportunities marked approved in Graphora’s rollout plan. Publication and applications depend on the required materials and launch readiness. This is a platform pipeline status—not regulatory approval or a recommendation to invest.
What happens next: Waiting for preparation and release. Planned opportunity groups may be included before individual pages are available.
Being evaluated for potential inclusion.
Potential opportunities in Graphora’s review queue. They have not moved into the approved launch pipeline and are not available to apply to through these pipeline entries.
What happens next: May move to the approved pipeline after review; inclusion and timing are not guaranteed.
Waiting for evaluation or more information.
Potential opportunities waiting for review or enough information to progress. They are not approved or live. This is a queue of opportunities—not a waiting list of Graphora members.
What happens next: Additional information and prioritization are needed before moving into review.
Available to explore includes information-only pages; application status is shown separately. Fund and company/SPV raises are additive. Fundraising targets, not capital raised or committed. Some targets describe company rounds rather than Graphora allocations. Under-review and waitlist amounts are estimates. Trends include corrected targets and stage changes; they are not investment returns.
Registry updated 2026-10-16 · Changes versus 2026-09-27. Legacy pipeline estimates remain dated 2026-09-27.

Human ambition. AI-native intelligence.
The people, purpose and progress behind the platform.
Our story and history ↗Want to help build Graphora itself? Explore our current Associate and advisory opportunities.
Explore careers at Graphora ↗Your next chapter starts with you
So could your retirement capital. Explore the possibilities, the requirements, and where you fit.
Membership starts free. Some services may require a paid plan. Investment access is subject to requirements.